---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-004711"
form_type: "8-K"
ticker: "OGN"
cik: "0001821825"
company_name: "Organon & Co."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:23:40.758074+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organon CCO Susanne Fiedler departs effective Jan 15, senior advisor until April 30

## Summary
- Susanne Fiedler ceased performing CCO functions effective January 15, 2025.
- She will serve as a senior advisor until departure expected on or about April 30, 2025.
- No successor has been named; the Company did not disclose the reason for departure.

## SEC filing metadata
- accession: 0001104659-25-004711
- form_type: 8-K
- ticker: OGN
- cik: 0001821825
- company_name: Organon & Co.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821825/000110465925004711/0001104659-25-004711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821825/000110465925004711/tm253756d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-004711
- JSON: https://secwatch.observer/filing/0001104659-25-004711.json
- Plain text: https://secwatch.observer/filing/0001104659-25-004711.txt

## Key facts
- Executive change
  Susanne Fiedler departed as Chief Commercial Officer at Organon & Co..
  - Action: ceased performing her functions
  - Role: Chief Commercial Officer
  source text: On January 15, 2025, Organon & Co. (the “ Company ”) announced that effective January 15, 2025, Susanne Fiedler ceased performing her functions as Chief Commercial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1821825/000110465925004711/0001104659-25-004711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.